Structural blueprint for RNA therapeutics reveals why some siRNA molecules work better than others

RNA interference is a natural mechanism for living cells to control whether specific genes are being used. Crowned with the ...

Understudied enzyme helps S. aureus pathogen prosper, study finds

A new study published in the Proceedings of the National Academy of Sciences has offered insight into how Staphylococcus ...
The Lancet

Comparison of sitafloxacin monotherapy versus doxycycline plus rifampicin for acute uncomplicated human brucellosis: a multicenter, randomized, open-label, non-inferiority trial

Sitafloxacin monotherapy was non-inferior to doxycycline–rifampicin for treating acute uncomplicated brucellosis, and showed a favorable safety and tolerability profile. Thus, sitafloxacin monotherapy ...
Scientific American

How CRISPR could target the body’s epigenome—the software that controls our genes

A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...